Home › Research › Topics › r47h-trem2
r47h-trem2
2 studies tagged r47h-trem2, dated 2021-06-25 to 2022-12-08. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss 2022-12-08
- Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome 2021-06-25
Studies
2 studies carry this tag.
Date range
2021 to 2022
Top journals
- Glia 1
- Scientific reports 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Triggering receptor on myeloid cells 2 (TREM2) is an innate immune receptor, upregulated on the surface of microglia associated with amyloid plaques in Alzheimer's disease (AD).
-
The R47H variant of the microglial membrane receptor TREM2 is linked to increased risk of late onset Alzheimer's disease.